TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
BIO

Bio-Rad Laboratories Inc

Healthcare · Medical Devices

379.60$ +0.6% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Bio-Rad Laboratories Inc (BIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 651 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
632 681 611 638 650 667 585 652 653 693 592 651 2,589
296 315 284 283 294 326 279 306 310 348 283 305 1,246
336 366 326 355 356 342 306 345 343 345 309 346 1,344
44 62 64 59 91 80 74 61 71 66 63 61 261
201 207 215 195 200 204 209 208 207 221 212 212 852
245 268 274 254 291 284 282 268 278 282 275 273 1,109
91 98 52 101 64 58 24 77 66 62 34 73 235
12 12 12 12 12 12 12 13 12 12 12 12 49
137 428 491 -2,786 862 -909 83 414 -431 929 -690 542 350
31 79 107 -621 208 -193 19 96 -89 209 -163 171 128
106 350 384 -2,165 653 -716 64 318 -342 720 -527 371 222
198 494 551 -2,727 923 -847 134 477 -365 994 -637 542 535

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?